Listed pharmaceutical companies recorded a significant boost in profits and revenues for the period ended 30th June as increase in the demand for prescription drugs and other medical interventions rose on heightened health-consciousness amid the COVID-19 pandemic.
Analysis of recently released
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
